Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Ever Supreme Bio Technology Co's share price is NT$148.50.
Ever Supreme Bio Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$11.01. Hence, Ever Supreme Bio Technology Co's PS Ratio for today is 13.48.
The historical rank and industry rank for Ever Supreme Bio Technology Co's PS Ratio or its related term are showing as below:
ROCO:6712'
s PS Ratio Range Over the Past 10 Years
Min: 11.11 Med: 22.88 Max: 4581.99
Current: 13.48
During the past 10 years, Ever Supreme Bio Technology Co's highest PS Ratio was 4581.99. The lowest was 11.11. And the median was 22.88.
ROCO:6712's PS Ratio is ranked worse than 59.03% of 930
companies
in the Biotechnology industry
Industry Median: 9.23
vs ROCO:6712: 13.48
During the past 10 years, Ever Supreme Bio Technology Co's highest 3-Year average Revenue per Share Growth Rate was 273.30% per year. The lowest was 18.90% per year. And the median was 71.70% per year.
Ever Supreme Bio Technology Co (ROCO:6712) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Ever Supreme Bio Technology Co PS Ratio Related Terms
Ever Supreme Bio Technology Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6712 vs VRTX, REGN, RVMD: PS Ratio Comparison
For the Biotechnology subindustry, Ever Supreme Bio Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ever Supreme Bio Technology Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ever Supreme Bio Technology Co's PS Ratio falls into.
Ever Supreme Bio Technology Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Ever Supreme Bio Technology Co's Share Price of today is NT$148.50. Ever Supreme Bio Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$11.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Ever Supreme Bio Technology Co (ROCO:6712) has a PS Ratio of 13.48 as of Aug. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 41% below median its historical median of 22.88. Over the past decade, Ever Supreme Bio Technology Co's PS Ratio has ranged from 11.11 to 4,581.99. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #549 out of 930 companies in the Biotechnology industry, placing it in the top 59%.
Is Ever Supreme Bio Technology Co's PS Ratio too high?
Ever Supreme Bio Technology Co's current PS Ratio of 13.48 is 41% below median its 10-year median of 22.88. Over the past 10 years, this metric has ranged from a low of 11.11 to a high of 4,581.99. The Biotechnology industry median PS Ratio is 9.23. Ever Supreme Bio Technology Co's value of 13.48 is 46% above this industry median. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #549 out of 930 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #549 out of 930 companies for PS Ratio. This places Ever Supreme Bio Technology Co in the lower half of its industry. The industry median PS Ratio is 9.23. Ever Supreme Bio Technology Co's value of 13.48 is 46% above this benchmark. Historically, Ever Supreme Bio Technology Co's own PS Ratio has ranged from 11.11 to 4,581.99 over the past decade. While the company's 10-year median is 22.88 vs. the industry median of 9.23, Ever Supreme Bio Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.23, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ever Supreme Bio Technology Co's current PS Ratio of 13.48 is 46% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Ever Supreme Bio Technology Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ever Supreme Bio Technology Co's current PS Ratio is 13.48, which is 41% below median its own 10-year median of 22.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$191.19, compared to a current price of NT$148.50 — trading 22.3% below its estimated fair value. The current PS Ratio is 13.48, which is 41% below median its 10-year median of 22.88 and 46% above the Biotechnology industry median of 9.23. Ever Supreme Bio Technology Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current PS Ratio is 13.48 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued.
The current stock price of NT$148.50 is trading 22.3% below its estimated GF Value™ of NT$191.19.
GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:6712:
PS Ratio: 13.48 (41% below median its 10-year median of 22.88)
GF Value™: NT$191.19 vs. price of NT$148.50 (22.3% below fair value)
Industry Position: 46% above the Biotechnology median (#549 of 930)
No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
91GF Score
Get the complete analysis for ROCO:6712
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6712 has been successfully added to your 
